ROTHBLATT MARTINE A
High convictionDirector, Chairperson & CEO · UNITED THERAPEUTICS Corp
Every open-market stock purchase ROTHBLATT MARTINE A has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- UTHRUNITED THERAPEUTICS Corp
One purchase totalling $863.9K at an average of $575.96 per share. See all insider buying in UTHR →
Avg price paid$575.96Latest price—Market capUnknown
All reported buys
Get alerted the next time ROTHBLATT MARTINE A — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from ROTHBLATT MARTINE A's Form 4 filings on SEC EDGAR (CIK 1106578) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.